Trademarkia Logo

Canada

C$
Trademark Search in Canada
DIAGNOSTICS DEFINING THERAPY
DIAGNOSTICS DEFINING THERAPY
DEFAULT - SEARCHED

on 3 Jan 2025

Last Applicant/ Owned by

SpeeDx Pty Ltd

Suite G16, National Innovation CentreAustralian Technology Park4 Cornwallis StreetEveleigh NEW SOUTH WALES 2015

AU

Serial Number

1937687 filed on 21st Dec 2018

Correspondent Address

MOFFAT & CO.

P.O. Box 2088, Station DOttawa

ONTARIO

CA

K1P5W3

DIAGNOSTICS DEFINING THERAPY

Trademark usage description

chemicals used in science being primers and chemical preparations for scientific purposes (other than for medical or veterinary use), namely for in vi Read More

Classification Information


Class [001]
Chemicals used in science being primers and chemical preparations for scientific purposes (other than for medical or veterinary use), namely for in vitro use in biochemistry, clinical chemistry and microbiology, photography, agriculture, horticulture and forestry; reagents and reactants other than for medical or veterinary purpose, namely diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; enzymes for industrial or scientific purposes namely for diagnostic testing purposes in the field of in vitro diagnostic use namely, for use in the diagnosis of diseases or detection or identification of pathogens; nucleic recombinant acids; acids being inorganic and organic acids being for vitro use in biochemistry, clinical chemistry, microbiology and diagnostic testing purposes; polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring being chemicals for the control of environmental pollution, reagents for use in environmental analysis, reagents for use in environmental testing


Classification kind code

12

Class [005]
Pharmaceutical and veterinary preparations and substances being preparation and substances comprising of nucleic acid sequences for diagnostic and therapeutic use, including in vitro diagnostic use, namely, for use in the diagnosis of diseases or detection or identification of pathogens; reagents for medical and veterinary use being reagents comprising of nucleic acid sequences for diagnostic and therapeutic use, including diagnostic use, namely, for use in the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; nucleic acid amplification reagents for medical use for diagnostic and therapeutic use, including in vitro diagnostic use; nucleic acid sequencing programs for medical use for diagnostic and therapeutic use, including in vitro diagnostic use; Chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens; Chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for diagnostic and therapeutic use, including diagnostic use, for the diagnosis of diseases or detection or identification of pathogens; enzymes for pharmaceutical, veterinary and medical purposes, for diagnostic and therapeutic use, including diagnostic use, for the diagnosis of diseases or detection or identification of pathogens; Medical kits consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; Clinical diagnostics for medical and veterinary use using nucleic acid sequences, including in vitro diagnostic use, namely, for use in the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders


Classification kind code

12

Class [010]
Surgical, medical and veterinary apparatus and instruments namely amplification controls quantitative polymerase chain reaction tests for use in relation to surgery, for veterinary use, for medical diagnostic and therapeutic use namely gene expression, protein expression, metabolite expression, inflammation, immune suppression, immune disorders; Diagnostic testing apparatus containing biomarker reagents for use in gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders; Diagnostic testing kits containing biomarker reagents for use in gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders; Point of care medical devices namely amplification controls quantitative polymerase chain reaction tests for gene therapy use, namely in relation to gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders; screening kits for the diagnosis of disease, detection of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection of epigenetic alterations, analysis of response to therapy; screening kits for the diagnosis of disease, identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, analysis of epigenetic alterations, analysis of response to therapy


Classification kind code

12

Class [042]
Scientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, and scientific research consulting in the field of genetics; genetic research; genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services, namely, chemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of diagnostic apparatus for genetics research; design of diagnostic apparatus for genetics research; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests in the field of genetics and genetic engineering, infectious diseases, immunological diseases and autoimmune diseases; biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services for scientific and medical research; DNA and RNA and polynucleic acid and protein sequencing, analysis and evaluation services for scientific and medical research; genome sequencing services and the analysis and evaluation of data resulting therefrom for scientific testing and scientific research purposes; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific research and development services; custom design and development of biochemical assays; molecular diagnostics testing


Classification kind code

12

Class [044]
Medical services; human health care services in the fields of genetics and genetic engineering, infectious diseases, immunological diseases and autoimmune diseases; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to DNA, genetics and genetic testing, namely, DNA screening for medical purposes and genetic testing for medical purposes; medical diagnostic services in the nature of medical testing services and medical analysis services relating to patient treatment; providing collected and analysed medical information in the field of genetic disorders and treatment information for diseases and disorders for diagnostic and treatment purposes


Classification kind code

12

Mark Details


Serial Number

1937687

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 6
on 3rd Jan 2025
Abandoned - Section 36
Submitted for opposition 14
on 16th Oct 2024
Default Notice Sent
Submitted for opposition 15
on 28th Mar 2024
Correspondence Created
Submitted for opposition 12
on 26th Aug 2022
Extension of Time
Submitted for opposition 22
on 31st Jan 2022
Search Recorded
Submitted for opposition 20
on 31st Jan 2022
Examiner's First Report
Submitted for opposition 31
on 2th Jan 2019
Formalized
Submitted for opposition 1
on 27th Dec 2018
Created
Submitted for opposition 30
on 21st Dec 2018
Filed